Chromatin structure, transcriptional activity and DNA repair efficiency affect the outcome of chemotherapy in multiple myeloma

BACKGROUND: Melphalan is one of the most active chemotherapeutic agents in the treatment of multiple myeloma (MM). However, the mechanism underlying differential patient responses to melphalan therapy is unknown. METHODS: Chromatin structure, transcriptional activity and DNA damage response signals...

Descripción completa

Detalles Bibliográficos
Autores principales: Gkotzamanidou, M, Sfikakis, P P, Kyrtopoulos, S A, Bamia, C, Dimopoulos, M A, Souliotis, V L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4183844/
https://www.ncbi.nlm.nih.gov/pubmed/25051404
http://dx.doi.org/10.1038/bjc.2014.410

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4183844/
https://www.ncbi.nlm.nih.gov/pubmed/25051404
http://dx.doi.org/10.1038/bjc.2014.410

Ejemplares similares